Research Article
Urinary Catheterization May Not Adversely Impact Quality of Life in Multiple Sclerosis Patients
Table 3
Catheter used based on reported impact on quality of life and impact on disability, bladder complaints, and spasticity.
| | Group | Reported positive change in QoL | Reported no change on QoL | Reported negative change in QoL | value* |
| | Catheterizing patients (1193) | | | | | | Intermittent (727) | 387 (61.5%) | 148 (56.9%) | 192 (63.2%) | 0.631 | | Indwelling (169) | 87 (13.8%) | 42 (16.1%) | 40 (13.2%) | 0.779 | | Suprapubic (169) | 101 (16.1%) | 34 (13.1%) | 34 (11.2%) | 0.047 | | Unsure (128) | 54 (8.6%) | 36 (13.8%) | 38 (12.5%) | 0.060 | | PDDS score ≥ 3 | 562 (89.3%) | 218 (83.8%) | 256 (84.2%) | 0.025 | | Bladder score ≥ 3 | 400 (63.6%) | 141 (54.2%) | 225 (74.0%) | 0.002 | | Spasticity score ≥ 3 | 298 (47.4%) | 110 (42.3%) | 176 (57.9%) | 0.003 |
|
|
value for comparison between positive and negative columns.
|
